Group 1 - Company closed at 127.18 yuan, up 4.25%, with a rolling PE ratio of 83.06 times and a total market value of 104.816 billion yuan [1] - The average PE ratio in the medical device industry is 46.46 times, with a median of 33.07 times, placing the company at the 105th position [1] - As of the Q3 2024 report, 551 institutions hold shares in the company, with a total of 133.2164 million shares valued at 16.839 billion yuan [1] Group 2 - For Q3 2024, the company reported revenue of 6.954 billion yuan, a year-on-year decrease of 6.43%, and a net profit of 671 million yuan, down 36.94% [2] - The company's gross profit margin stands at 49.41% [2] - The company has undertaken nearly 40 national and provincial R&D projects, including around 20 national major science and technology projects [1]
联影医疗收盘上涨4.25%,滚动市盈率83.06倍,总市值1048.16亿元